About this episode
The episode discusses the potential economic impacts of weight-loss drugs and falling obesity rates.
Will weight-loss drugs fuel the global economy, or give it indigestion? Host Carmel Crimmins talks to Michele Gershberg, global health editor and U.S. business editor David Gaffen about the impact of falling obesity rates on consumer spending, productivity and government finances. Sign up for the Reuters Econ World newsletter Produced by Eliza Davis Beard Sound engineering and music by Josh Sommer Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt out of targeted advertising. Our Standards: **The Thomson Reuters Trust Principles.** Further listening Dating apps Is Big Tech too big to slow down? Labor market limbo Learn more about your ad choices. Visit megaphone.fm/adchoices
People in this episode
Host: Carmel Crimmins
Guests: Michele Gershberg, David Gaffen
Topics covered
- weight-loss drugs
- global economy
- consumer spending
- productivity
- government finances
- obesity rates
Keywords
- weight-loss drugs
- global economy
- consumer spending
- productivity
- obesity rates
- government finances
Mentioned in this episode
Organizations: Reuters, Thomson Reuters
More episodes of Reuters Econ World
- The World Cup economy · June 10, 2026 · 32 min
- Class dismissed: The economics of U.S. higher education · June 3, 2026 · 37 min
- Trump’s problem · May 27, 2026 · 39 min
- Inside Europe’s shortest workweek · May 20, 2026 · 37 min
- Kevin Warsh’s policy trap · April 22, 2026 · 34 min
- The economics of $60-plus cigarettes · April 15, 2026 · 34 min
Explore listener stats, chart rankings, contacts and more on the Reuters Econ World podcast page.